Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Cash from Investing Activities: 2019-2025

Historic Cash from Investing Activities for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$67,000.

  • Biodesix's Cash from Investing Activities rose 76.57% to -$67,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 78.71%. This contributed to the annual value of -$3.4 million for FY2024, which is 85.08% up from last year.
  • Per Biodesix's latest filing, its Cash from Investing Activities stood at -$67,000 for Q3 2025, which was up 29.47% from -$95,000 recorded in Q2 2025.
  • Biodesix's 5-year Cash from Investing Activities high stood at -$67,000 for Q3 2025, and its period low was -$7.7 million during Q1 2023.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$884,000 (2024), whereas its average is -$2.4 million.
  • As far as peak fluctuations go, Biodesix's Cash from Investing Activities slumped by 2,089.20% in 2023, and later soared by 96.46% in 2024.
  • Biodesix's Cash from Investing Activities (Quarterly) stood at -$641,000 in 2021, then crashed by 209.98% to -$2.0 million in 2022, then crashed by 51.03% to -$3.0 million in 2023, then skyrocketed by 70.54% to -$884,000 in 2024, then soared by 76.57% to -$67,000 in 2025.
  • Its last three reported values are -$67,000 in Q3 2025, -$95,000 for Q2 2025, and -$137,000 during Q1 2025.